Perrigo (PRGO) Profit After Tax (2012 - 2026)
Perrigo (PRGO) posted quarterly Profit After Tax of -$389.8 million for Q1 2026, down 5990.62% year-over-year from $6.6 million in Q1 2025, and up 72.89% quarter-over-quarter from -$1.4 billion in Q4 2025.
Perrigo (PRGO) Profit After Tax (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Profit After Tax for 15 consecutive years, with -$389.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax fell 5990.62% year-over-year to -$389.8 million; the TTM figure through Mar 2026 stood at -$1.7 billion (down 886.64% YoY), while the FY2025 annual figure was -$1.4 billion, down 786.99% from the prior year.
- Profit After Tax advanced to -$389.8 million in Q1 2026 per PRGO's latest filing, from -$1.4 billion in the prior quarter.
- Across five years, Profit After Tax topped out at $145.4 million in Q2 2025 and bottomed at -$1.4 billion in Q4 2025.
- Historically, Profit After Tax has averaged -$123.5 million across 5 years, with a median of -$21.0 million in 2024.
- Annual changes were most pronounced in 2025 — Profit After Tax jumped 234.13% — and 2026, when it slumped 5990.62%.
- Perrigo's Profit After Tax stood at -$12.7 million in 2022, then plunged by 118.11% to -$27.7 million in 2023, then slipped by 20.58% to -$33.4 million in 2024, then plunged by 4204.49% to -$1.4 billion in 2025, then soared by 72.89% to -$389.8 million in 2026.
- Business Quant data shows PRGO's Profit After Tax at -$389.8 million in Q1 2026, -$1.4 billion in Q4 2025, and $12.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Perrigo | 1.93 Bn | 1.53 Bn | 313.90 Mn | 88.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 88.50 Mn |
| Mar 28, 2026 | -389.80 Mn |
| Dec 31, 2025 | -1.44 Bn |
| Sep 27, 2025 | 12.70 Mn |
| Jun 28, 2025 | 145.40 Mn |
| Mar 29, 2025 | -6.40 Mn |
| Dec 31, 2024 | -33.40 Mn |
| Sep 28, 2024 | -21.00 Mn |
| Jun 29, 2024 | -108.40 Mn |
| Mar 30, 2024 | -48.40 Mn |
| Dec 31, 2023 | -27.70 Mn |
| Sep 30, 2023 | 15.40 Mn |
| Jul 1, 2023 | 26.20 Mn |
| Apr 1, 2023 | 20.70 Mn |
| Dec 31, 2022 | -12.70 Mn |
| Oct 1, 2022 | -52.10 Mn |
| Jul 2, 2022 | -161.80 Mn |
| Apr 2, 2022 | -20.50 Mn |
| Dec 31, 2021 | 32.10 Mn |
| Oct 2, 2021 | -53.90 Mn |